Resource Hub
Donate Now
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Sustaining a Polio-free World
Sustaining a Polio-free World strategy
Transition Planning
OPV Cessation
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
The Virus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
Polio-Free Countries
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
Innovative Financing
News
Media Centre
Take Action
Donate
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Sustaining a Polio-free World
Sustaining a Polio-free World strategy
Transition Planning
OPV Cessation
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
The Virus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
Polio-Free Countries
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
Innovative Financing
News
Media Centre
Take Action
Donate
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Access to Vaccines
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Integration
- Integration - Country Highlights
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resource Hub
Annual Consultation between the GPEI and polio vaccine manufacturers, National Authorities for Containment and National Regulatory Authorities
WER: Progress towards poliomyelitis eradication – Afghanistan, January 2023–September 2024 | 13 December 2024, Vol. 99, No. 50, pp. 745–754
156th Executive Board – 2025 | Poliomyelitis
arabic
|
chinese
|
english
|
french
|
russian
|
spanish
|
WER: Meeting of the Strategic Advisory Group of Experts on Immunization, September 2024: conclusions and recommendations | 6 December 2024, Vol. 99, No. 49, pp. 719–740
Polio eradication strategy 2022-2026: delivering on a promise, extension to 2029
GPEI Multi-Year Budget Explainer 2022-2029
7th TIMB Report – October 2024
WER: Routine vaccination coverage – worldwide, 2023 | 1 Nov 2024; vol.99, No.44, 641-652
23rd Consultation between the GPEI and polio vaccine manufacturers, National Authorities for Containment and National Regulatory Authorities
WER: Update on vaccine-derived poliovirus outbreaks – worldwide, January 2023 – June 2024 | 18 Oct 2024; vol.99, No.42, 596
Annual Report 2023
GCC-National Authorities for Containment meeting reports
Sixth meeting
|
Fifth meeting
|
Fourth meeting
|
Third meeting
|
Second meeting
|
First meeting
|
Technical Advisory Group Meeting for Afghanistan and Pakistan | 22-25 May 2024
24th meeting of the Global Commission for the Certification of Eradication of Poliomyelitis, 22-23 November 2023
23rd Report – September 2024
1
…
3
4
5
6
7
…
47
